[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-112424-en":3,"doc-seo-112424-105":28,"detail-sidebar-cat-0-en-105":88},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"doc_content":15,"file_id":16,"file_url":17,"file_type":18,"file_size":19,"view_count":4,"is_deleted":4,"is_public":20,"is_downloadable":20,"audit_status":20,"page_count":20,"language":21,"language_code":22,"site_id":23,"html_lang":22,"table_of_contents":24,"faqs":25,"seo_title":13,"seo_description":14,"update_tm":26,"read_time":27},112424,5909877438554,"Maeve","https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272",8,"Research & Report","Record of Approval on an Absence-of-Objection Basis - Türkiye Investment in the e2vc Fund III","Approval documentation records a board decision made on Thursday, June 25, 2026 under an absence-of-objection basis. The decision authorizes an investment in Türkiye through the e2vc Fund III, referencing Türkiye-Proposed Investment in the e2vc Fund III (IFC/R2026-0220, dated June 12, 2026). The package includes equity funding up to EUR 15 million and a delegated-authority co-investment envelope up to EUR 10 million for future opportunities alongside the fund. Alexey Nickolaevich Morozov is noted as abstaining.","Public Disclosure Authorized Public Disclosure Authorized  \nThe following item has been approved on an Absence-of-Objection Basis  \non Thursday, June 25, 2026  \nTürkiye  \nInvestment in  \nthe e2vc Fund III  \nThe Board of Directors approved on June 25, 2026 an investment in Türkiye-Proposed Investment in the e2vc Fund III (IFC/R2026-0220, dated June 12, 2026) consisting of (i) an equity investment of up to EUR 15 million in the e2vc Fund III; and (ii) a co-investment envelope of up to EUR 10 million on a delegated authority basis (IFC/R2016-0225) to participate in potential future co-investment opportunities alongside the e2vc Fund III. Alexey Nickolaevich Morozov wished to be recorded as abstaining.","cbCaivzwoYZBHRyk","https://ap.wps.com/l/cbCaivzwoYZBHRyk","pdf",46373,1,"English","en",105,"# Approval Summary\n## Decision Date and Framework\n## Investment Structure (Equity and Co-Investment)\n## Noted Abstention","[{\"question\":\"When was the investment approval recorded under the absence-of-objection basis?\",\"answer\":\"The approval was recorded on Thursday, June 25, 2026.\"},{\"question\":\"What investment amounts were approved for the e2vc Fund III?\",\"answer\":\"The board approved equity investment of up to EUR 15 million and a delegated-authority co-investment envelope of up to EUR 10 million.\"},{\"question\":\"Who indicated abstention, and what does it mean in this record?\",\"answer\":\"Alexey Nickolaevich Morozov wished to be recorded as abstaining, indicating he did not vote in favor while the board’s decision was recorded.\"}]",1784494976,3,{"code":4,"msg":29,"data":30},"ok",{"site_id":23,"language":22,"slug":31,"title":13,"keywords":32,"description":14,"schema_data":33,"social_meta":83,"head_meta":85,"extra_data":87,"updated_unix":26},"record-of-approval-on-an-absence-of-objection-basis-turkiye-investment-in-the-e2vc-fund-iii","",{"@graph":34,"@context":82},[35,51,65],{"@type":36,"itemListElement":37},"BreadcrumbList",[38,42,46,48],{"item":39,"name":40,"@type":41,"position":20},"https://docshare.wps.com","Home","ListItem",{"item":43,"name":44,"@type":41,"position":45},"https://docshare.wps.com/document/","Document",2,{"item":47,"name":12,"@type":41,"position":27},"https://docshare.wps.com/document/research-report/",{"item":49,"name":13,"@type":41,"position":50},"https://docshare.wps.com/document/record-of-approval-on-an-absence-of-objection-basis-turkiye-investment-in-the-e2vc-fund-iii/112424/",4,{"url":49,"name":13,"@type":52,"author":53,"headline":13,"publisher":55,"fileFormat":58,"inLanguage":22,"description":14,"dateModified":59,"datePublished":59,"encodingFormat":58,"isAccessibleForFree":60,"interactionStatistic":61},"DigitalDocument",{"name":9,"@type":54},"Person",{"url":39,"name":56,"@type":57},"DocShare","Organization","application/pdf","2026-07-19",true,{"@type":62,"interactionType":63,"userInteractionCount":4},"InteractionCounter",{"@type":64},"ViewAction",{"@type":66,"mainEntity":67},"FAQPage",[68,74,78],{"name":69,"@type":70,"acceptedAnswer":71},"When was the investment approval recorded under the absence-of-objection basis?","Question",{"text":72,"@type":73},"The approval was recorded on Thursday, June 25, 2026.","Answer",{"name":75,"@type":70,"acceptedAnswer":76},"What investment amounts were approved for the e2vc Fund III?",{"text":77,"@type":73},"The board approved equity investment of up to EUR 15 million and a delegated-authority co-investment envelope of up to EUR 10 million.",{"name":79,"@type":70,"acceptedAnswer":80},"Who indicated abstention, and what does it mean in this record?",{"text":81,"@type":73},"Alexey Nickolaevich Morozov wished to be recorded as abstaining, indicating he did not vote in favor while the board’s decision was recorded.","https://schema.org",{"og:url":49,"og:type":84,"og:title":13,"og:site_name":56,"og:description":14},"article",{"robots":86,"canonical":49},"index,follow",{"doc_id":7,"site_id":23},{"code":4,"msg":5,"data":89},[90,94,98,102,107,112,117,120,125,128,132],{"id":20,"doc_module":4,"doc_module_name":44,"category_name":91,"show_sort_weight":92,"slug":93},"Story & Novel",90,"story-novel",{"id":45,"doc_module":4,"doc_module_name":44,"category_name":95,"show_sort_weight":96,"slug":97},"Literature",80,"literature",{"id":50,"doc_module":4,"doc_module_name":44,"category_name":99,"show_sort_weight":100,"slug":101},"Exam",70,"exam",{"id":103,"doc_module":4,"doc_module_name":44,"category_name":104,"show_sort_weight":105,"slug":106},5,"Comic",60,"comic",{"id":108,"doc_module":4,"doc_module_name":44,"category_name":109,"show_sort_weight":110,"slug":111},6,"Technology",50,"technology",{"id":113,"doc_module":4,"doc_module_name":44,"category_name":114,"show_sort_weight":115,"slug":116},7,"Healthcare",40,"healthcare",{"id":11,"doc_module":4,"doc_module_name":44,"category_name":12,"show_sort_weight":118,"slug":119},30,"research-report",{"id":121,"doc_module":4,"doc_module_name":44,"category_name":122,"show_sort_weight":123,"slug":124},9,"Religion & Spirituality",20,"religion-spirituality",{"id":123,"doc_module":4,"doc_module_name":44,"category_name":126,"show_sort_weight":123,"slug":127},"World Cup","world-cup",{"id":129,"doc_module":4,"doc_module_name":44,"category_name":130,"show_sort_weight":129,"slug":131},10,"Lifestyle","lifestyle",{"id":133,"doc_module":4,"doc_module_name":44,"category_name":134,"show_sort_weight":103,"slug":135},19,"General","general"]